Karin E Bornfeldt

19PUBLICATIONS
75CO-AUTHORS
Molecular targetsCardiology (incl. cardiovascular diseases)Haematological tumoursDisease surveillanceEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 22, 2026
SGLT2 inhibition modulates metabolic, vascular, and inflammatory molecular markers in the kidney in youth with type 1 diabetes.

|Jun 04, 2026
Lipoproteins in Cardiovascular Disease: Building on Successes to Meet Future Challenges.

|Jun 04, 2026
Triglyceride-Rich Lipoprotein Metabolism and Cardiovascular Risk in Diabetes: Bedside to Bench to Bedside.

|Jan 03, 2026
Non-remnant triglyceride-rich lipoproteins due to lipoprotein lipase deficiency increase atherosclerosis in mice.

Ainara G Cabodevilla, Maria Concepcion Izquierdo, Debapriya Basu

|Jul 25, 2025
Elevated apolipoprotein C3 heightens atherosclerosis risk by mediating arterial accumulation of free cholesterol and local inflammation in diabetes.

Jenny E Kanter, Cheng-Chieh Hsu, Farah Kramer

|Jul 03, 2024
High-Density Lipoprotein Particle Concentration and Size Predict Incident Coronary Artery Disease Events in a Cohort With Type 1 Diabetes.

Tina Costacou, Tomas Vaisar, Rachel G Miller

Pageof 4

Frequent Collaborators

8 joint publications

Jenny E Kanter

5 joint publications

Tomas Vaisar

4 joint publications

Cheng-Chieh Hsu

4 joint publications

Vishal Kothari